445 related articles for article (PubMed ID: 26578404)
1. Patient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?
Schmitz A; Schulz C; Friebel U; Hohlfeld T; Bausewein C
J Pain Symptom Manage; 2016 Mar; 51(3):581-8. PubMed ID: 26578404
[TBL] [Abstract][Full Text] [Related]
2. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
[TBL] [Abstract][Full Text] [Related]
3. EffenDys-Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial.
Simon ST; Kloke M; Alt-Epping B; Gärtner J; Hellmich M; Hein R; Piel M; Cornely OA; Nauck F; Voltz R
J Pain Symptom Manage; 2016 Nov; 52(5):617-625. PubMed ID: 27693898
[TBL] [Abstract][Full Text] [Related]
4. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
5. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
6. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
Clemens KE; Klaschik E
Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
[TBL] [Abstract][Full Text] [Related]
7. Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study.
Johnson MJ; McDonagh TA; Harkness A; McKay SE; Dargie HJ
Eur J Heart Fail; 2002 Dec; 4(6):753-6. PubMed ID: 12453546
[TBL] [Abstract][Full Text] [Related]
8. Nebulized morphine in the palliation of dyspnoea.
Zeppetella G
Palliat Med; 1997 Jul; 11(4):267-75. PubMed ID: 9373577
[TBL] [Abstract][Full Text] [Related]
9. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.
Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H
Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380
[TBL] [Abstract][Full Text] [Related]
10. Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
Currow DC; Quinn S; Ekstrom M; Kaasa S; Johnson MJ; Somogyi AA; Klepstad P
BMJ Open; 2015 May; 5(5):e006818. PubMed ID: 25948405
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
12. Comparison of respiratory health-related quality of life in patients with intractable breathlessness due to advanced cancer or advanced COPD.
Javadzadeh S; Chowienczyk S; Booth S; Farquhar M
BMJ Support Palliat Care; 2016 Mar; 6(1):105-8. PubMed ID: 26685116
[TBL] [Abstract][Full Text] [Related]
13. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
[TBL] [Abstract][Full Text] [Related]
14. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
[TBL] [Abstract][Full Text] [Related]
15. Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.
Kawaguchi J; Hamatani Y; Hirayama A; Nishimura K; Nakai E; Nakamura E; Miyata M; Kawano Y; Takada Y; Anchi Y; Funabashi S; Kuroda K; Azechi M; Takahama H; Anzai T; Yasuda S; Kitaoka H; Izumi C
J Cardiol; 2020 Jun; 75(6):682-688. PubMed ID: 32061472
[TBL] [Abstract][Full Text] [Related]
16. Management of Breathlessness in Patients With Advanced Cancer: A Narrative Review.
Lok CW
Am J Hosp Palliat Care; 2016 Apr; 33(3):286-90. PubMed ID: 25318928
[TBL] [Abstract][Full Text] [Related]
17. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline.
Charles MA; Reymond L; Israel F
J Pain Symptom Manage; 2008 Jul; 36(1):29-38. PubMed ID: 18358689
[TBL] [Abstract][Full Text] [Related]
18. Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough.
Oxberry SG; Bland JM; Clark AL; Cleland JG; Johnson MJ
J Palliat Med; 2013 Mar; 16(3):250-5. PubMed ID: 23368980
[TBL] [Abstract][Full Text] [Related]
19. Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial.
Oxberry SG; Torgerson DJ; Bland JM; Clark AL; Cleland JG; Johnson MJ
Eur J Heart Fail; 2011 Sep; 13(9):1006-12. PubMed ID: 21712288
[TBL] [Abstract][Full Text] [Related]
20. Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.
Hui D; Kilgore K; Frisbee-Hume S; Park M; Liu D; Balachandran DD; Bruera E
J Pain Symptom Manage; 2017 Dec; 54(6):798-805. PubMed ID: 28803087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
